M. Scott Harris
2023
In 2023, M. Scott Harris earned a total compensation of $2.2M as Chief Medical Officer at PharmAthene, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,520 |
|---|---|
| Option Awards | $1,080,331 |
| Salary | $487,569 |
| Stock Awards | $477,848 |
| Other | $2,720 |
| Total | $2,239,988 |
Harris received $1.1M in option awards, accounting for 48% of the total pay in 2023.
Harris also received $191.5K in non-equity incentive plan, $487.6K in salary, $477.8K in stock awards and $2.7K in other compensation.
Rankings
In 2023, M. Scott Harris' compensation ranked 458th out of 2,978 executives tracked by ExecPay. In other words, Harris earned more than 84.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 458 out of 2,978 | 85th |
Division Manufacturing | 264 out of 1,637 | 84th |
Major group Chemicals And Allied Products | 180 out of 906 | 80th |
Industry group Drugs | 177 out of 869 | 80th |
Industry Pharmaceutical Preparations | 110 out of 627 | 83rd |
Source: SEC filing on August 15, 2024.
Harris' colleagues
We found two more compensation records of executives who worked with M. Scott Harris at PharmAthene in 2023.